Acurx Pharmaceuticals, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €0.00
    Gross profit
    €0.00
    SG&A expenses
    €5.93M
    R&D expenses
    €2.72M
    EBITDA
    -€8.63M
    D&A
    €2.44M
    EBIT
    -€8.65M
    Interest expenses
    €0.00
    EBT
    -€8.63M
    Tax expenses
    €3.78M
    Net income
    -€8.63M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €964.35M
    Changes in working capital
    -€270.71K
    Operating cash flow
    -€7.04M
    Capex
    €0.00
    Other investing cash flow
    €0.00
    Net investing cash flow
    €0.00
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €4.65M
    Debt repayment
    €0.00
    Other financing cash flow
    €8.29B
    Net financing cash flow
    €8.12B
    Foreign exchange effects
    €0.00
    Net change in cash
    €807.75M
    Cash at end of period
    €5.23M
    Free cash flow
    -€7.04M

    Balance sheet

    Cash and cash equivalents
    €5.23M
    Cash and short-term investments
    €5.23M
    Total receivables
    €34.70K
    Inventory
    €0.00
    Other current assets
    €46.19K
    Total current assets
    €5.31M
    Property, plant & equipment
    €0.00
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €0.00
    Total non-current assets
    €0.00
    Total assets
    €5.31M
    Accounts payable
    €0.00
    Short-term debt
    €0.00
    Other current liabilities
    €2.24M
    Total current liabilities
    €2.24M
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €0.00
    Total liabilities
    €2.24M
    Common stock
    €1.27K
    Retained earnings
    -€61.89M
    Other equity
    €0.00
    Total equity
    €3.08M
    Total liabilities and shareholders' equity
    €5.31M

    Company information

    Market capitalization
    €9.30M
    Employees
    4
    Enterprise Value
    €3.57M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -280.4% Much worse than peer group: -174.1%
    ROA
    -162.4% Much better than peer group: -616.0%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -75.7%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€2.16M

    Notifications